{"id":"W4282832327","doi":"10.1136/rmdopen-2022-002286","title":"Improved patient-reported outcomes in patients with psoriatic arthritis treated with risankizumab: analysis of the Phase 3 trial KEEPsAKE 2","year":2022,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Psoriatic arthritis; Visual analogue scale; Placebo; Internal medicine; Physical therapy; Quality of life (healthcare); Minimal clinically important difference; Dermatology Life Quality Index; Randomized controlled trial; Arthritis; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009105416,0.001237522,0.002882181,0.0002768359,0.0003653132,0.001228176,0.000825809,0.001319077,0.003670759],"category_scores_gemma":[0.005609515,0.0005318756,0.004880227,0.0004423755,0.0007958217,0.0009307611,0.0006755927,0.002496813,0.0004360242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007059274,"about_ca_system_score_gemma":0.001463793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006314432,"about_ca_topic_score_gemma":0.001594582,"domain_scores_codex":[0.9959669,0.003085614,0.000197447,0.0002591449,0.0002840253,0.000206916],"domain_scores_gemma":[0.9954305,0.001780407,0.001548576,0.0004411114,0.0002057112,0.0005936465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9670751,0.00448636,0.005257176,0.00059587,0.003232878,0.0000476684,0.00007493901,0.001065565,0.002174234,0.0000767741,0.0008383156,0.015075],"study_design_scores_gemma":[0.8000859,0.1648428,0.02868786,0.00007877829,0.002803779,0.00009181385,0.00005255353,0.001645031,0.0005983588,0.000180832,0.0008846385,0.00004757793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991897,0.00382439,0.0004288394,0.0005463443,0.0001254211,0.0009141107,0.001414225,0.00004853456,0.0008010559],"genre_scores_gemma":[0.9917883,0.001217216,0.0009737162,0.0007317696,0.000228708,0.001906281,0.002351055,0.00002566074,0.0007774144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009105416,"threshold_uncertainty_score":0.04815459,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01291427857416632,"score_gpt":0.2761819780022461,"score_spread":0.2632676994280798,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}